-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOGEN AND STOKE THERAPEUTICS PRESENT DATA THAT FURTHER SUPPORT THE DISEASE-MODIFYING POTENTIAL OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF DRAVET SYNDROME, AT THE 2025 AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING

路透·12/05/2025 14:00:01

登录查看新闻详情